ProPhase Labs, Inc. (PRPH): Total Assets
$59.87M
As of 2025-12-31
$57.41M
As of 2026-06-30
-11.9%
3-year compound annual growth
+13.8%
5-year compound annual growth
+15.0%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $59.87M | -5.3% | 2026-06-01, Balance as of period end |
| 2024-12-31 | $63.20M | -31.2% | 2026-06-01, Balance as of period end |
| 2023-12-31 | $91.93M | +4.9% | 2025-04-01, Balance as of period end |
| 2022-12-31 | $87.65M | -1.8% | 2024-03-29, Balance as of period end |
| 2021-12-31 | $89.30M | +184.3% | 2023-03-29, Balance as of period end |
| 2020-12-31 | $31.41M | +155.9% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $12.27M | -40.8% | 2021-03-31, Balance as of period end |
| 2018-12-31 | $20.74M | -38.4% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $33.66M | +162.9% | 2019-03-26, Balance as of period end |
| 2016-12-31 | $12.80M | -13.7% | 2018-08-20, Balance as of period end |
| 2015-12-31 | $14.83M | -7.6% | 2017-02-24, Balance as of period end |
| 2014-12-31 | $16.06M | -7.8% | 2016-03-29, Balance as of period end |
| 2013-12-31 | $17.42M | +4.6% | 2015-03-27, Balance as of period end |
| 2012-12-31 | $16.66M | -12.7% | 2014-03-27, Balance as of period end |
| 2011-12-31 | $19.08M | -12.1% | 2013-03-28, Balance as of period end |
| 2010-12-31 | $21.70M | n/a | 2012-03-07, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | 2025-12-31 | $59.87M | -5.3% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $31.00M | +108.2% |
| CervoMed Inc. (CRVO) | 2025-12-31 | $22.88M | -46.9% |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | $7.45M | +33.1% |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | $19.07M | -13.4% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $117.81M | +50.4% |
| TherapeuticsMD, Inc. (TXMD) | 2025-12-31 | $37.66M | -3.0% |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | $8.36M | +21.2% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $113.51M | -49.8% |
Compare PRPH, CPHI, CRVO, ENSC side by side · Screen every company in Pharmaceutical Preparations ↗